Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Donald Tsai, MD PhD

Assistant Professor of Medicine
University of Pennsylvania Cancer Center
Member of the Healthcare Council

Donald Tsai, MD, PhD, is an Assistant Professor of Medicine at the University of Pennsylvania Cancer Center. Dr. Tsai specializes in the treatment of hematological malignancies such as leukemia, multiple myeloma, lymphoma, Hodgkin's disease, myelodysplastic syndromes (MDS), and bone marrow transplantation. He also has expertise with the following therapies: Revlimid, Rituxan, lymphoma vaccines (BioVaxID, genitope, Favrille), Velcade, Procrit, Aranesp, Campath, Zevalin, Bexxar, epratuzumab (anti-CD22 antibody), thalidomide, Vidaza, Dacogen, Targretin, ONTAK, STR, and other new therapies. (This is me - Update Profile)


Employment History
2000 - present Assistant Professor of Medicine
University of Pennsylvania Cancer Center

GLG Study Groups with Donald Tsai, MD PhD(?)

View All Study Groups with Donald Tsai, MD PhD

GLG NewsSM Analyses by Donald Tsai, MD PhD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Donald Tsai, MD PhD has not published any public GLG News analyses.
View all GLG News in Healthcare

GLG InstituteSM Seminars with Donald Tsai, MD PhD(?)

 

Recent Seminars

GLGi: Chinese Copper Market Review and Outlook
Hong Kong, 05-22-2007

Request a project with Donald Tsai, MD PhD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics